SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000849146-15-000027
Filing Date
2015-02-04
Accepted
2015-02-04 16:01:45
Documents
11
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q lfvn_123114x10q.htm 10-Q 677715
2 CEO CERTIFICATION lfvn_123114xex311.htm EX-31.1 11510
3 CFO CERTIFICATION lfvn_123114xex312.htm EX-31.2 11510
4 CEO CERTIFICATION lfvn_123114xex321.htm EX-32.1 5641
5 CFO CERTIFICATION lfvn_123114xex322.htm EX-32.2 5641
  Complete submission text file 0000849146-15-000027.txt   3728774

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT lfvn-20141231.xml EX-101.INS 385861
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20141231.xsd EX-101.SCH 21812
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lfvn-20141231_cal.xml EX-101.CAL 52591
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfvn-20141231_def.xml EX-101.DEF 85874
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20141231_lab.xml EX-101.LAB 365312
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20141231_pre.xml EX-101.PRE 194785
Mailing Address 9815 S. MONROE STREET SUITE 100 SANDY UT 84070
Business Address 9815 S. MONROE STREET SUITE 100 SANDY UT 84070 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

IRS No.: 841097796 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35647 | Film No.: 15575386
SIC: 2834 Pharmaceutical Preparations